Newsfeeds - Spark Newswire

1 minute read

Dr. Reddy’s Seeks Gaining Foothold In Women’s Health Via Mayne Pharma’s U.S. Generic Prescription Deal

Today, 3:01 AM

Dr. Reddy’s Laboratories Ltd (NYSE:RDY) has agreed to acquire the U.S. generic prescription product portfolio of Australia-based Mayne Pharma Group Limited (OTC:MAYND) (OTC:MAYNF)…

MAYND

1 minute read

M&A
News

Dr. Reddy’s Laboratories Announced Late Sunday Agreement To Acquire Mayne Pharma’s U.S. Generic Prescription Product Portfolio

By Charles Gross

Today, 3:01 AM

Dr. Reddy's Laboratories SA, wholly-owned subsidiary of Dr. Reddy's Laboratories Ltd. (NYSE: RDY) announced that it has entered into a definitive agreement to acquire the U.S. generic prescription product portfolio of Salisbury, Australia, based Mayne Pharma Group Limited (ASX: MYX).

RDY

1 minute read

Barclays Maintains Overweight on Dr Reddy’s Laboratories, Raises Price Target to $69

By Benzinga Newsdesk

Today, 3:01 AM

Barclays analyst Balaji Prasad maintains Dr Reddy's Laboratories (NYSE:RDY) with a Overweight and raises the price target from $68 to $69.

RDY

1 minute read

News

Dr. Reddy’s Laboratories Ltd Gets Establishment Inspection Report For Srikakulam, Andhra Pradesh Facility

By Benzinga Newsdesk

Today, 3:01 AM

- Reuters

RDY

1 minute read

Intercept Settles Ocaliva Litigation With Reddy’s Lab

By Vandana Singh

Today, 3:01 AM

Intercept Pharmaceuticals Inc (NASDAQ:ICPT) and its subsidiary Intercept Pharma Europe Limited settled patent litigation with Dr. Reddy’s Laboratories Ltd (NYSE:RDY). The litigation concerns…

ICPT

2 minute read

Dr. Reddy’s Laboratories Announces The Acquisition Of An Injectable Product Portfolio From Eton Pharma For ~$5M In Cash, Up To $45M In Contingent Payments

By Benzinga Newsdesk

Today, 3:01 AM

Dr. Reddy's Laboratories Ltd. ((BSE: 500124, NSE: DRREDDY, NYSE:RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as "Dr. Reddy's")) today announced that it has acquired a

ETON

8 minute read

FDA
News

Dr. Reddy’s Laboratories And Senores Pharmaceuticals, Inc. Announce The Launch Of Ketorolac Tromethamine Tablets USP, 10mg In The U.S. Market

By Benzinga Newsdesk

Today, 3:01 AM

Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. announce the launch of Ketorolac Tromethamine Tablets USP, 10 mg in the U.S. market Dr. Reddy's Laboratories Ltd. ((BSE: 500124, NSE: DRREDDY, NYSE:RDY,

RDY